Vol 62, No 1 (2011)
Review paper
Published online: 2011-03-01
Osteonecrosis of the jaw
Endokrynol Pol 2011;62(1):88-92.
Abstract
This review looks at osteonecrosis in the stomatognathic system (mainly the jaws). Osteonecrosis of the jaw (ONJ) is a rare but serious
clinical condition. It affects patients treated with bisphosphonates, and also with denosumab, mainly in oncological doses. In osteoporosis,
it is a problem of relatively small significance. Article presents a thorough review of this phenomenon, including its definition, pathogenesis,
risk factors, prevention and treatment methods, and its incidence rate. (Pol J Endocrinol 2011; 62 (1): 88-92)
Keywords: osteonecrosis of the jawbisphosphonatesdenosumab
